講演情報
[WS11-08-P]Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients
○Ryuji Owada1, Takeru Kashiwada2, Ryotaro Takano1,3, Fumihiko Ando1,3, Shoko Kuroda1, Yoshishige Miyabe1,4, Tomoko Asatsuma-Okumura1, Masahiro Seike2, Yoshiko Iwai1 (1.Department of Cell Biology, Institute of Advanced Medical Sciences, Nippon Medical School, 2.Department of Pulmonary Medicine and Oncology, Nippon Medical School, 3.Department of Gastrointestinal and Hepato-Biliary-pancreatic surgery, Nippon Medical School, 4.Department of Immunology and Parasitology, St. Marianna University School of Medicine)
キーワード:
soluble PD-L1、inflammation、macrophage、lysosomal degradation、immune-related adverse event
閲覧にはパスワードが必要です
ログイン
または